- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 6th, 2005
One of the latest, most promising treatments for some women with metastatic breast cancer is a new drug that increases the response rate of tumors and causes fewer side effects, researchers say.
The technology behind the drug, nanoparticle albumin-bound paclitaxel (nab-paclitaxel or AbraxaneTM) marks a breakthrough, say Vicente Valero M.D., and Edgardo Rivera, M.D., both in the Department of Breast Medical Oncology at M. D. Anderson.
|Related News Press|
Nanoscale Trojan horses treat inflammation May 24th, 2016
Programmable materials find strength in molecular repetition May 23rd, 2016
Dartmouth team creates new method to control quantum systems May 24th, 2016
Attosecond physics: A switch for light-wave electronics May 24th, 2016